(Q38947288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

review article

1 reference

title

Lung cancer screening: latest developments and unanswered questions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Carlijn M van der Aalst

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Harry J de Koning

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

1 September 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

The Lancet. Respiratory medicine

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

749-761

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

22 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Survival of patients with stage I lung cancer detected on CT screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The National Lung Screening Trial: overview and study design

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The Danish randomized lung cancer CT screening trial--overall design and results of the prevalence round

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Four-year results of low-dose CT screening and nodule management in the ITALUNG trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Reduced lung-cancer mortality with low-dose computed tomographic screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Lung cancer screening with low-dose computed tomography: an analysis of the MEDCAC decision

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Annual number of lung cancer deaths potentially avertable by screening in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Cost-effectiveness of CT screening in the National Lung Screening Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Cost-effectiveness of Lung Cancer Screening in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Application of risk prediction models to lung cancer screening: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Benefits and harms of CT screening for lung cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Results of initial low-dose computed tomographic screening for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The impact of a lung cancer computed tomography screening result on smoking abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The British Thoracic Society guidelines on the investigation and management of pulmonary nodules

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Overdiagnosis in lung cancer screening: why modelling is essential

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Overdiagnosis in low-dose computed tomography screening for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Selection criteria for lung-cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Targeting of low-dose CT screening according to the risk of lung-cancer death

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Management of lung nodules detected by volume CT scanning.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Probability of cancer in pulmonary nodules detected on first screening CT.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the USA: a simulation modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Integrating smoking cessation into lung cancer screening programs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Brief Tailored Smoking Cessation Counseling in a Lung Cancer Screening Population is Feasible: A Pilot Randomized Controlled Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

A combined smoking cessation intervention within a lung cancer screening trial: a pilot observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Effectiveness of smoking cessation interventions among adults: a systematic review of reviews

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

European Code against Cancer, 4th Edition: Cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Visual scoring of coronary artery calcification in lung cancer screening computed tomography: association with all-cause and cardiovascular mortality risk.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Lung cancer screening CT-based prediction of cardiovascular events.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930200-4

7 January 2021

10.1016/S2213-2600(16)30200-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27599248%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference